2 October 2025

APLAR Rheumatology

Australia makes its mark at APLAR 2025

2 October 2025

Dermatology PBAC PBS Pharmaceuticals

‘Unsustainable’: Pfizer pulls out of JAKi PBS application

18 September 2025

Mental Health

Autoimmune disease nearly doubles mental health risk

18 September 2025

Biologics Lupus

Anifrolumab moves closer to self-administration

18 September 2025

Biologics

Biologics trigger unexpected hair loss

18 September 2025

APLAR Rheumatology

APLAR 2025 sets new benchmarks in rheumatology

18 September 2025

Clinical research Immunotherapy Rheumatoid Arthritis

Immune reset therapy prepares to enter RA trials

18 September 2025

Guidelines

New European CTD-ILD guidelines back disease-specific approach

4 September 2025

Pharmaceuticals

Ianalumab hits phase III milestone in Sjögren’s

4 September 2025

Government Rheumatoid Arthritis

PM marks Arthritis Australia’s 75 years

4 September 2025

Menopause Women

‘Shameful’: hormone tests offer no value

4 September 2025

Osteoarthritis Sport

Noisy knees after ACL surgery not a red flag for early arthritis

4 September 2025

Arthritis Public Health

Australia underestimates arthritis at its peril

4 September 2025

Clinical research Osteoarthritis

Virtual and hybrid rehab stacks up

21 August 2025

Vaccination

Recombinant zoster vaccine effective and safe in adults with SLE

21 August 2025

Rheumatoid Arthritis

JAKis linked to Hep B reactivation risk in RA patients